← Leaderboards
Peter Nagele
Washington University
$3,465,890
Attributed
$3,890,077
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $705.7K · FY2010–21$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,890,077 · 4
By mechanism
R01$2,530,592 · 1
R21$848,375 · 2
K23$511,110 · 1
Top collaborators
- Emil F Coccaro2 shared
- Charles Richard Conway2 shared
Most similar at Washington University
Same institution · by research overlap
- Vesna Jevtovic-Todorovic Jevtovic-Todorovic$12,218,628
- John W Olney$12,066,208
- Joshua S Shimony$7,166,593
- Slobodan M Todorovic$10,566,929
- Alex S Evers$14,189,581
Others in their field
Top investigators on “American”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Ethan Schreier · Associated Universities, Inc.$207,732,557
Research focus
AmericanPlacebosEventPreventTranslatingPostoperative PeriodRandomized Controlled TrialsHigh RiskPerioperativeRandomizedIncidenceAnesthesia ProceduresMyocardial IschemiaMyocardial InfarctionClinical TrialsOperative Surgical ProceduresCardiacCardiac DeathSafetyInvestigationInnovationNitrous OxideFutureMental Depression
Grant awards (14)
Nitrous Oxide and Cortico-Limbic Function in Aggression$234,000
R21 · FY2021 · MH
Nitrous Oxide and Cortico-Limbic Function in Aggression$195,000
R21 · FY2020 · MH
Novel Strategy for Perioperative Beta-Blocker Therapy$506,498
R01 · FY2019 · HL · contact PI
Novel Strategy for Perioperative Beta-Blocker Therapy$506,649
R01 · FY2018 · HL · contact PI
NOVEL STRATEGY FOR PERIOPERATIVE BETA-BLOCKER THERAPY$476,938
R01 · FY2017 · HL · contact PI
NMDA RECEPTOR ANTAGONIST NITROUS OXIDE TARGETS AFFECTIVE BRAIN CIRCUITS$190,625
R21 · FY2017 · MH
NOVEL STRATEGY FOR PERIOPERATIVE BETA-BLOCKER THERAPY$476,938
R01 · FY2016 · HL · contact PI
NMDA RECEPTOR ANTAGONIST NITROUS OXIDE TARGETS AFFECTIVE BRAIN CIRCUITS$228,750
R21 · FY2016 · MH
NOVEL STRATEGY FOR PERIOPERATIVE BETA-BLOCKER THERAPY$563,569
R01 · FY2015 · HL · contact PI
Perioperative pharmacogenetics: Nitrous oxide and anesthetic outcomes$114,673
K23 · FY2013 · GM · contact PI
Perioperative pharmacogenetics: Nitrous oxide and anesthetic outcomes$114,572
K23 · FY2012 · GM · contact PI
Perioperative pharmacogenetics: Nitrous oxide and anesthetic outcomes$114,125
K23 · FY2011 · GM · contact PI
Perioperative pharmacogenetics: Nitrous oxide and anesthetic outcomes$113,740
K23 · FY2010 · GM · contact PI
Perioperative pharmacogenetics: Nitrous oxide and anesthetic outcomes$54,000
K23 · FY2010 · GM · contact PI